default author photo

Qi Wang

Tongji University - Shanghai Pulmonary Hospital

SCHOLARLY PAPERS

3

DOWNLOADS

185

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Camrelizumab Plus Nab-Paclitaxel and Carboplatin as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer (ES-SCLC): A Phase II Trial

Number of pages: 19 Posted: 05 Feb 2024
Jia Yu, Anwen Xiong, Lei Wang, Xinlong Zheng, Tao Jiang, Qi Wang, Bin Chen, Menghang Yang, Wei Li, Jiajia Yuan, Changhong Zhao, Xiaohui Chen, Caicun Zhou and Shengxiang Ren
Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Fujian Medical University - Fujian Medical University Cancer Hospital, Tongji University - Department of Oncology, Tongji University - Shanghai Pulmonary Hospital, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Tongji University - Department of Oncology, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Fujian Medical University - Department of Thoracic Surgery, Tongji University - Department of Medical Oncology and Tongji University - Department of Medical Oncology
Downloads 86 (765,566)

Abstract:

Loading...

Camrelizumab, Nab-paclitaxel, Immunotherapy, ES-SCLC

2.

Exploratory Biomarker Analysis of PD-1/CTLA-4 Bispecific Antibody Therapy Response in PD-L1-Negative Advanced Non-Small Cell Lung Cancer: Genomic and Transcriptomic Profiling from the Phase II LungCadX Study

Number of pages: 35 Posted: 19 Aug 2025
Li Wang, Zhixuan Ren, Qi Wang, Li Liu, Shuai Lv, Minwei Bao, Tianqing Chu, Chuangzhou Rao, Jianing Chen, Tianlin Sun, Changbin Zhu, Jialin Qu and Chunxia Su
Tongji University, Fudan University - Huadong Hospital, Tongji University - Shanghai Pulmonary Hospital, Tongji University, University of South China, Tongji University, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, University of Chinese Academy of Sciences, Tongji University, Amoy Diagnostics Co., Ltd., Amoy Diagnostics Co., Ltd., Qingdao University - Cancer Precision Medicine Center and Tongji University - Department of Medical Oncology
Downloads 66 (907,769)

Abstract:

Loading...

Non-small-cell lung cancer, PD-L1-negative, PD-1/CTLA-4 bispecific antibody, Patient-derived organoid, IFN-γ signaling pathway

3.

Differential Organ-Specific Tumor Response to First-Line Immune Checkpoint Inhibitors Therapy in NSCLC

Number of pages: 19 Posted: 23 Sep 2022
Qi Wang, Haoyue Guo, Chao Zhao, Lei Cheng, Xuefei Li, Zhemin Zhang and Caicun Zhou
Tongji University - Shanghai Pulmonary Hospital, Tongji University - Tongji University Cancer Center, Tongji University - Shanghai Pulmonary Hospital, Tongji University - Shanghai Pulmonary Hospital, Tongji University - Shanghai Pulmonary Hospital, Tongji University - Shanghai Pulmonary Hospital and Tongji University - Shanghai Pulmonary Hospital
Downloads 33 (1,277,121)

Abstract:

Loading...

Lung cancer, Immune checkpoint inhibitor, Tumor microenvironment, Tumor response